statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	16.850
EU - Europa	8.876
AS - Asia	2.533
SA - Sud America	42
OC - Oceania	37
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	11
Totale	28.371

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	16.800
IT - Italia	4.752
UA - Ucraina	1.541
CN - Cina	910
TR - Turchia	653
SE - Svezia	630
VN - Vietnam	552
IE - Irlanda	545
GB - Regno Unito	415
FI - Finlandia	373
DE - Germania	317
SG - Singapore	278
FR - Francia	71
NL - Olanda	59
CA - Canada	43
IN - India	35
AU - Australia	28
JP - Giappone	26
AT - Austria	23
RU - Federazione Russa	23
BE - Belgio	22
BR - Brasile	22
CZ - Repubblica Ceca	20
KR - Corea	20
PL - Polonia	12
ES - Italia	11
EU - Europa	11
CH - Svizzera	10
NZ - Nuova Zelanda	9
RO - Romania	9
CL - Cile	7
HK - Hong Kong	7
PE - Perù	7
IR - Iran	6
MA - Marocco	6
MX - Messico	6
MY - Malesia	6
NO - Norvegia	6
TW - Taiwan	6
GR - Grecia	5
NG - Nigeria	5
AE - Emirati Arabi Uniti	4
HU - Ungheria	4
ID - Indonesia	4
KZ - Kazakistan	4
MD - Moldavia	4
SA - Arabia Saudita	4
AL - Albania	3
AR - Argentina	3
BG - Bulgaria	3
CO - Colombia	3
DK - Danimarca	3
DZ - Algeria	3
EG - Egitto	3
LK - Sri Lanka	3
MM - Myanmar	3
PK - Pakistan	3
PT - Portogallo	3
ZA - Sudafrica	3
BA - Bosnia-Erzegovina	2
HR - Croazia	2
IL - Israele	2
KH - Cambogia	2
LT - Lituania	2
LU - Lussemburgo	2
SK - Slovacchia (Repubblica Slovacca)	2
BD - Bangladesh	1
GH - Ghana	1
JO - Giordania	1
LV - Lettonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MZ - Mozambico	1
PA - Panama	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
Totale	28.371

Salva come PNG Salva come JPEG

Città	#
Milan	3.384
Fairfield	2.338
Woodbridge	1.831
Jacksonville	1.255
Houston	1.208
Ann Arbor	1.207
Ashburn	1.198
Chandler	1.100
Wilmington	923
Seattle	918
Cambridge	788
Princeton	532
Dublin	527
Shenzhen	435
Dearborn	410
Boardman	380
Izmir	372
Nyköping	314
Dong Ket	285
Rome	268
Singapore	241
San Diego	166
Como	126
New York	122
San Mateo	120
Chicago	112
Ogden	104
London	72
Hefei	71
Dallas	70
Beijing	66
Washington	64
Falls Church	57
Helsinki	53
Kocaeli	49
Santa Clara	47
Nanjing	43
Kunming	38
Norwalk	36
Los Angeles	32
San Genesio Ed Uniti	32
Verona	27
Düsseldorf	23
Munich	23
Redmond	23
Toronto	23
Amsterdam	22
Jinan	22
Redwood City	22
Guangzhou	21
Tokyo	21
Vienna	21
Brussels	20
San Francisco	20
Magnago	18
Kilburn	17
Phoenix	17
Brno	16
Philadelphia	16
Pavia	15
Indiana	14
Nanchang	14
Chiswick	13
New Bedfont	13
Chennai	12
Prescot	12
Bari	11
Chengdu	11
Shenyang	11
São Paulo	11
Hangzhou	10
Baotou	9
Espoo	9
Lappeenranta	9
Naples	9
Shanghai	9
Edinburgh	8
Fuzhou	8
Melbourne	8
Montreal	8
Pune	8
Southwark	8
Warsaw	8
Zhengzhou	8
Acton	7
Changsha	7
Meppel	7
Auburn Hills	6
Beauharnois	6
Brisbane	6
Chongqing	6
Cicciano	6
Florence	6
Hebei	6
Hounslow	6
Kuala Lumpur	6
Lima	6
Menlo Park	6
Oslo	6
Varese	6
Totale	22.121

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	551
The effects of a cognitive behavioural intervention in asthmatic patients.	205
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	189
Airway inflammation in patients affected by obstructive sleep apnea	188
Classifying new anti-tuberculosis drugs: rationale and future perspectives	182
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery.	180
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	176
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	172
Clinical and operational value of the extensively drug-resistant tuberculosis definition.	170
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	170
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	168
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	167
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	166
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.	166
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	166
History of tuberculosis and drug resistance	165
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	165
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.	164
Aging and airway inflammation	162
When kidneys and lungs suffer together	162
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics.	161
Tuberculosis elimination: theory and practice in Europe	161
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	161
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	161
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance.	160
Economic analysis of two structured treatment and teaching programs on asthma.	159
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	159
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	157
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate.	157
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	157
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.	156
Improving the TB case management: The International Standards for Tuberculosis Care.	156
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation.	155
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	155
In vitro susceptibility testing and totally drug-resistant tuberculosis	154
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	154
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	153
Induced sputum to assess airway inflammation: a study of reproducibility.	153
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	153
A new Editorial Board of Monaldi Archives for Chest Disease	152
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.	151
Effects of intradermal injection of atrial natriuretic peptide.	151
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	151
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	150
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	150
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	150
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	149
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.	149
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.	147
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	146
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	146
Menopausal asthma: a new biological phenotype?	146
Ripped from the headlines: how can we harness communications to control TB?	145
An electronic nose in the discrimination of patients with asthma and controls.	145
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	145
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.	144
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	144
Recent developments in the diagnosis and management of tuberculosis	144
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.	143
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	143
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution.	143
Aging and induced-sputum cells.	142
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.	142
Comparison of two methods of processing induced sputum: selected versus entire sputum.	141
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.	141
SPUTUM AND EXHALED BREATH ANALYSIS	139
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact.	138
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: A non-inferiority, randomised, double-blind clinical trial	138
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	137
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	137
Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018	137
Effect of methacholine challenge on cellular composition of sputum induction.	136
MDR-TB and XDR-TB: drug resistance and treatment outcomes.	136
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	136
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.	136
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.	135
Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?	135
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.	134
Airway inflammation in healthy smokers.	134
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	134
Is bronchodilator the correct treatment for COPD subjects before EBUS?	134
Latex allergy and sensitization in cities: a survey in a population at risk	134
Exhaled inflammatory markers in aspirin-induced asthma syndrome.	134
Development of a Barthel Index based on dyspnea for patients with respiratory diseases	133
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	133
Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis.	131
Management of drug resistantTB in patients with HIV co-infection	131
Brittle Asthma	130
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis	130
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	130
Markers of airway inflammation in pulmonary diseases assessed by induced sputum.	130
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	129
Sputum induced cellularity in a group of traffic policemen.	129
Eosinophilia in asthma: The easy way is not always the best	129
Genotyping of microsatellite alterations and EGFR somatic mutations in exhaled breath condensate of NSCLC patients	128
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD	128
Tuberculosis elimination: Where are we now?	128
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.	126
WHO strategies for the programmatic management of drug-resistant tuberculosis	126
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.	125
Totale	15.256

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	122.529
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	122.529

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	3.373	0	0	0	0	327	551	750	608	389	332	101	315
2020/2021	4.355	119	355	210	385	275	413	196	373	635	283	418	693
2021/2022	2.742	315	328	168	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	1.215	53	93	781	151	137	0	0	0	0	0	0	0
Totale													29.017